Synairgen Statistics
Total Valuation
Synairgen has a market cap or net worth of 110,266. The enterprise value is -5.59 million.
| Market Cap | 110,266 |
| Enterprise Value | -5.59M |
Important Dates
The last earnings date was Friday, December 26, 2025.
| Earnings Date | Dec 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Synairgen has 1.10 billion shares outstanding.
| Current Share Class | 1.10B |
| Shares Outstanding | 1.10B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 10.50% |
| Float | 142.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.01 |
| P/TBV Ratio | 0.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.66 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.57 |
Financial Position
The company has a current ratio of 4.94
| Current Ratio | 4.94 |
| Quick Ratio | 4.60 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -71.94% and return on invested capital (ROIC) is -54.95%.
| Return on Equity (ROE) | -71.94% |
| Return on Assets (ROA) | -47.20% |
| Return on Invested Capital (ROIC) | -54.95% |
| Return on Capital Employed (ROCE) | -132.59% |
| Weighted Average Cost of Capital (WACC) | 12.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -250,790 |
| Employee Count | 34 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.97% in the last 52 weeks. The beta is 1.45, so Synairgen's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -99.97% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 32.83 |
| Average Volume (20 Days) | 3,524 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.61 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.42M |
| Pretax Income | -9.93M |
| Net Income | -8.53M |
| EBITDA | -10.38M |
| EBIT | -10.42M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 5.70 million in cash and n/a in debt, with a net cash position of 5.70 million or 0.01 per share.
| Cash & Cash Equivalents | 5.70M |
| Total Debt | n/a |
| Net Cash | 5.70M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 7.86M |
| Book Value Per Share | 0.04 |
| Working Capital | 7.61M |
Cash Flow
In the last 12 months, operating cash flow was -9.78 million and capital expenditures -117,681, giving a free cash flow of -9.90 million.
| Operating Cash Flow | -9.78M |
| Capital Expenditures | -117,681 |
| Free Cash Flow | -9.90M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Synairgen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | -0.11% |
| Earnings Yield | -7,732.99% |
| FCF Yield | -8,973.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |